The impact of erythroblast enucleation efficiency on the severity of anemia in patients with myelodysplastic syndrome.

An, Chao; Xue, Fumin; Sun, Ling; Han, Haiyan; Zhang, Yali; Hu, Yibo

An, Chao; Xue, Fumin; Sun, Ling; Han, Haiyan; Zhang, Yali; Hu, Yibo.

Afiliación

An C; Department of Clinical Laboratory, The Second Affiliated Hospital of Zhengzhou University, Zhengzhou, 450014, Henan, China. wwwanchao99@126.com.
Xue F; Henan Key Laboratory of Children's Genetics and Metabolic Diseases, Children's Hospital Affiliated to Zhengzhou University, Zhengzhou, 450000, Henan, China.
Sun L; Department of Hematology, First Affiliated Hospital of Zhengzhou University, Zhengzhou, 450052, China.
Han H; Department of Clinical Laboratory, The Second Affiliated Hospital of Zhengzhou University, Zhengzhou, 450014, Henan, China.
Zhang Y; Department of Clinical Laboratory, The Second Affiliated Hospital of Zhengzhou University, Zhengzhou, 450014, Henan, China.
Hu Y; Department of Clinical Laboratory, The Second Affiliated Hospital of Zhengzhou University, Zhengzhou, 450014, Henan, China. 15138680214@163.com.

Cell Commun Signal ; 21(1): 332, 2023 11 20.

Article en En | MEDLINE | ID: mdl-37986081

Asunto(s)

Anemia; Síndromes Mielodisplásicos; Humanos; Eritroblastos/metabolismo; Eritroblastos/patología; Síndromes Mielodisplásicos/complicaciones; Síndromes Mielodisplásicos/metabolismo; Anemia/complicaciones; Anemia/metabolismo; Anemia/patología; Factores de Riesgo; Células de la Médula Ósea/patología

Palabras clave

Anemia; Enucleation; MAPK/ERK; Myelodysplastic syndrome (MDS); PI3K/AKT

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Síndromes Mielodisplásicos / Anemia Límite: Humans Idioma: En Revista: Cell Commun Signal Año: 2023 Tipo del documento: Article País de afiliación: China

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google